AVAILABLE — Plain-Language Guides Compare Medications for Treatment of Osteoporosis

AHRQ released a new pair of plain-language guides to compare medications for the treatment of osteoporosis, including clinical benefits, risks, and cost estimates. Osteoporosis Treatments That Help Prevent Broken Bones, A Guide for Women After Menopause, and Fracture Prevention Treatments for Postmenopausal Women with Osteoporosis, a guide for clinicians. The consumer and clinician guides include basic facts about osteoporosis (also known as low bone density) and the medications commonly used in treatment. Among the medications analyzed are six bisphosphonates Fosamax, Didronel, Boniva, Aredia, Actonel and Zometa plus alternative treatments such as estrogen, calcitonin (a man made hormone), calcium, vitamin D, testosterone, parathyroid hormone, and selective estrogen receptors modules. Both guides include estimated monthly costs for the medications. The guides are the latest in a series of AHRQ publications that help clinicians and patients make the best possible treatment choices. Others guides produced by AHRQ compare treatments for diabetes, depression, gastroesophageal reflux disease, high blood pressure, narrowed kidney arteries and osteoarthritis. All guides will be available in Spanish. Copies of the guides are available by sending an e-mail to ahrqpubs@ahrq.gov